Robin Carhart-Harris, PhD

Title(s)Professor, Neurology
SchoolSchool of Medicine
ORCID ORCID Icon0000000260627150 Additional info
vCardDownload vCard

    Collapse Overview 

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. participants of Color: A longitudinal online survey study. J Affect Disord. 2024 Oct 22. Jones G, Lowe MX, Nayak S, Sepeda N, Kettner H, Carhart-Harris R, Jackson H, Garcia-Romeu A. PMID: 39447981.
      View in: PubMed   Mentions:    Fields:    
    2. Validation of the imperial psychedelic predictor scale. Psychol Med. 2024 Sep 27; 1-9. Angyus M, Osborn S, Haijen E, Erritzoe D, Peill J, Lyons T, Kettner H, Carhart-Harris R. PMID: 39327922.
      View in: PubMed   Mentions:    Fields:    
    3. Reply to Letter to the Editor: "Psychedelics in Older Adults: Difficulties of a Clear Therapeutic Evidence". Am J Geriatr Psychiatry. 2024 Sep 26. Kettner H, Roseman L, Gazzaley A, Carhart-Harris RL, Pasquini L. PMID: 39393967.
      View in: PubMed   Mentions:    Fields:    
    4. Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being. J Psychopharmacol. 2024 Oct; 38(10):887-896. Bonnelle V, Feilding A, Rosas FE, Nutt DJ, Carhart-Harris RL, Timmermann C. PMID: 39301949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects. Neurosci Conscious. 2024; 2024(1):niae033. Martial C, Carhart-Harris R, Timmermann C. PMID: 39220326; PMCID: PMC11363954.
      View in: PubMed   Mentions:
    6. Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors. medRxiv. 2024 Aug 28. Jiwani Z, Goldberg SB, Stroud J, Young J, Curtin J, Dunne JD, Simonsson O, Webb CA, Carhart-Harris R, Schlosser M. PMID: 39252913; PMCID: PMC11383514.
      View in: PubMed   Mentions:
    7. Psychotomimetic compensation versus sensitization. Pharmacol Res Perspect. 2024 Aug; 12(4):e1217. Brouwer A, Carhart-Harris RL, Raison CL. PMID: 38923845; PMCID: PMC11194300.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    8. A synergistic workspace for human consciousness revealed by Integrated Information Decomposition. Elife. 2024 Jul 18; 12. Luppi AI, Mediano PAM, Rosas FE, Allanson J, Pickard J, Carhart-Harris RL, Williams GB, Craig MM, Finoia P, Owen AM, Naci L, Menon DK, Bor D, Stamatakis EA. PMID: 39022924; PMCID: PMC11257694.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    9. Psilocybin desynchronizes the human brain. Nature. 2024 Aug; 632(8023):131-138. Siegel JS, Subramanian S, Perry D, Kay BP, Gordon EM, Laumann TO, Reneau TR, Metcalf NV, Chacko RV, Gratton C, Horan C, Krimmel SR, Shimony JS, Schweiger JA, Wong DF, Bender DA, Scheidter KM, Whiting FI, Padawer-Curry JA, Shinohara RT, Chen Y, Moser J, Yacoub E, Nelson SM, Vizioli L, Fair DA, Lenze EJ, Carhart-Harris R, Raison CL, Raichle ME, Snyder AZ, Nicol GE, Dosenbach NUF. PMID: 39020167; PMCID: PMC11291293.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy. Sci Rep. 2024 07 17; 14(1):16524. de la Salle S, Kettner H, Thibault Lévesque J, Garel N, Dames S, Patchett-Marble R, Rej S, Gloeckler S, Erritzoe D, Carhart-Harris R, Greenway KT. PMID: 39019922; PMCID: PMC11254907.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy. JAMA Netw Open. 2024 Jul 01; 7(7):e2422181. Roseman L, Erritzoe D, Nutt D, Carhart-Harris R, Timmermann C. PMID: 39008302; PMCID: PMC11250380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective? Front Hum Neurosci. 2024; 18:1402549. Pasculli G, Busan P, Jackson ES, Alm PA, De Gregorio D, Maguire GA, Goodwin GM, Gobbi G, Erritzoe D, Carhart-Harris RL. PMID: 38962146; PMCID: PMC11221540.
      View in: PubMed   Mentions:
    13. Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action". Front Psychiatry. 2024; 15:1320780. Bornemann J, Close JB, Ahmad K, Barba T, Godfrey K, Macdonald L, Erritzoe D, Nutt D, Carhart-Harris R. PMID: 38983371; PMCID: PMC11232672.
      View in: PubMed   Mentions:
    14. Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT. bioRxiv. 2024 May 30. Vohryzek J, Luppi AI, Atasoy S, Deco G, Carhart-Harris RL, Timmermann C, Kringelbach ML. PMID: 38853985; PMCID: PMC11160714.
      View in: PubMed   Mentions:
    15. Effects of Psychedelics in Older Adults: A Prospective Cohort Study. Am J Geriatr Psychiatry. 2024 Sep; 32(9):1047-1059. Kettner H, Roseman L, Gazzaley A, Carhart-Harris RL, Pasquini L. PMID: 38849218; PMCID: PMC11316630.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Brain substates induced by DMT relate to sympathetic output and meaningfulness of the experience. bioRxiv. 2024 Apr 17. Pasquini L, Simon AJ, Gallen CL, Kettner H, Roseman L, Gazzaley A, Carhart-Harris RL, Timmermann C. PMID: 38464275; PMCID: PMC10925211.
      View in: PubMed   Mentions:
    17. Psychedelics and the 'inner healer': Myth or mechanism? J Psychopharmacol. 2024 May; 38(5):417-424. Peill J, Marguilho M, Erritzoe D, Barba T, Greenway KT, Rosas F, Timmermann C, Carhart-Harris R. PMID: 38605658; PMCID: PMC11102647.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees. Front Psychiatry. 2024; 15:1279887. Lowe MX, Kettner H, Jolly DRP, Carhart-Harris RL, Jackson H. PMID: 38666090; PMCID: PMC11044680.
      View in: PubMed   Mentions:
    19. The flattening of spacetime hierarchy of the N,N-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework. Natl Sci Rev. 2024 May; 11(5):nwae124. Vohryzek J, Cabral J, Timmermann C, Atasoy S, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. PMID: 38778818; PMCID: PMC11110867.
      View in: PubMed   Mentions: 3  
    20. Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression. J Psychopharmacol. 2024 May; 38(5):458-470. Erritzoe D, Barba T, Spriggs MJ, Rosas FE, Nutt DJ, Carhart-Harris R. PMID: 38520045; PMCID: PMC11102650.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study. Res Sq. 2024 Mar 08. Kettner H, Roseman L, Gazzaley A, Carhart-Harris R, Pasquini L. PMID: 38496492; PMCID: PMC10942571.
      View in: PubMed   Mentions:
    22. The Relationship Between Changes in Mindfulness and Subsequent Changes in Well-Being Following Psychedelic Use: Prospective Cohort Study. JMIR Form Res. 2024 Mar 04; 8:e54632. Jones G, Herrmann F, Bear A, Carhart-Harris R, Kettner H. PMID: 38437005; PMCID: PMC10949123.
      View in: PubMed   Mentions:
    23. Psychiatric risks for worsened mental health after psychedelic use. J Psychopharmacol. 2024 03; 38(3):225-235. Marrocu A, Kettner H, Weiss B, Zeifman RJ, Erritzoe D, Carhart-Harris RL. PMID: 38491857; PMCID: PMC10944581.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity. J Affect Disord. 2024 May 15; 353:60-69. Copa D, Erritzoe D, Giribaldi B, Nutt D, Carhart-Harris R, Tagliazucchi E. PMID: 38423367.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Brain dynamics predictive of response to psilocybin for treatment-resistant depression. Brain Commun. 2024; 6(2):fcae049. Vohryzek J, Cabral J, Lord LD, Fernandes HM, Roseman L, Nutt DJ, Carhart-Harris RL, Deco G, Kringelbach ML. PMID: 38515439; PMCID: PMC10957168.
      View in: PubMed   Mentions: 6  
    26. Psychedelics and sexual functioning: a mixed-methods study. Sci Rep. 2024 02 07; 14(1):2181. Barba T, Kettner H, Radu C, Peill JM, Roseman L, Nutt DJ, Erritzoe D, Carhart-Harris R, Giribaldi B. PMID: 38326446; PMCID: PMC10850066.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Effects of DMT on mental health outcomes in healthy volunteers. Sci Rep. 2024 02 07; 14(1):3097. Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL. PMID: 38326357; PMCID: PMC10850177.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Development of the Japanese version of the Ego-Dissolution Inventory (EDI). Neuropsychopharmacol Rep. 2024 Mar; 44(1):292-297. Kusudo K, Tani H, Yonezawa K, Nakajima S, Nour MM, Carhart-Harris R, Uchida H. PMID: 38318991; PMCID: PMC10932788.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study. J Psychopharmacol. 2024 02; 38(2):145-155. Barbut Siva J, Barba T, Kettner H, Kuc J, Nutt DJ, Carhart-Harris R, Erritzoe D. PMID: 38281075; PMCID: PMC10863370.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. Psychol Med. 2024 Jun; 54(8):1717-1724. Szigeti B, Weiss B, Rosas FE, Erritzoe D, Nutt D, Carhart-Harris R. PMID: 38247730.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Effects of External Stimulation on Psychedelic State Neurodynamics. ACS Chem Neurosci. 2024 02 07; 15(3):462-471. Mediano PAM, Rosas FE, Timmermann C, Roseman L, Nutt DJ, Feilding A, Kaelen M, Kringelbach ML, Barrett AB, Seth AK, Muthukumaraswamy S, Bor D, Carhart-Harris RL. PMID: 38214686; PMCID: PMC10853937.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    32. A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex. Brain. 2024 01 04; 147(1):56-80. Luppi AI, Girn M, Rosas FE, Timmermann C, Roseman L, Erritzoe D, Nutt DJ, Stamatakis EA, Spreng RN, Xing L, Huttner WB, Carhart-Harris RL. PMID: 37703310.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Psilocybin and Other Classic Psychedelics in Depression. Curr Top Behav Neurosci. 2024; 66:149-174. Nutt DJ, Peill JM, Weiss B, Godfrey K, Carhart-Harris RL, Erritzoe D. PMID: 37955822.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. 5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk? Psychopharmacology (Berl). 2023 Dec 11. Dourron HM, Nichols CD, Simonsson O, Bradley M, Carhart-Harris R, Hendricks PS. PMID: 38072874.
      View in: PubMed   Mentions: 1     Fields:    
    35. Psychological and physiological effects of extended DMT. J Psychopharmacol. 2024 01; 38(1):56-67. Luan LX, Eckernäs E, Ashton M, Rosas FE, Uthaug MV, Bartha A, Jagger S, Gascon-Perai K, Gomes L, Nutt DJ, Erritzøe D, Carhart-Harris RL, Timmermann C. PMID: 37897244; PMCID: PMC10851633.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. LSD-induced changes in the functional connectivity of distinct thalamic nuclei. Neuroimage. 2023 Dec 01; 283:120414. Delli Pizzi S, Chiacchiaretta P, Sestieri C, Ferretti A, Tullo MG, Della Penna S, Martinotti G, Onofrj M, Roseman L, Timmermann C, Nutt DJ, Carhart-Harris RL, Sensi SL. PMID: 37858906.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    37. Case analysis of long-term negative psychological responses to psychedelics. Sci Rep. 2023 09 25; 13(1):15998. Bremler R, Katati N, Shergill P, Erritzoe D, Carhart-Harris RL. PMID: 37749109; PMCID: PMC10519946.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    38. Optimized infusion rates for N,N-dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework. CPT Pharmacometrics Syst Pharmacol. 2023 10; 12(10):1398-1410. Eckernäs E, Koomen J, Timmermann C, Carhart-Harris R, Röshammar D, Ashton M. PMID: 37675853; PMCID: PMC10583250.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences. Sci Rep. 2023 08 22; 13(1):13645. Zeifman RJ, Kettner H, Pagni BA, Mallard A, Roberts DE, Erritzoe D, Ross S, Carhart-Harris RL. PMID: 37608057; PMCID: PMC10444769.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing. Psychopharmacology (Berl). 2023 Aug 22. Dougherty RF, Clarke P, Atli M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin GM, Ryslik GA. PMID: 37606733.
      View in: PubMed   Mentions: 1     Fields:    
    41. The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosing. Sci Rep. 2023 07 26; 13(1):12107. Szigeti B, Nutt D, Carhart-Harris R, Erritzoe D. PMID: 37495637; PMCID: PMC10371989.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    42. Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis. Psychiatry Res. 2023 09; 327:115349. Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB. PMID: 37523886; PMCID: PMC10528683.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM. Psychol Med. 2024 Jan; 54(1):217. Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D. PMID: 37466289.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Pattern breaking: a complex systems approach to psychedelic medicine. Neurosci Conscious. 2023; 2023(1):niad017. Hipólito I, Mago J, Rosas FE, Carhart-Harris R. PMID: 37424966; PMCID: PMC10325487.
      View in: PubMed   Mentions: 6  
    45. In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape. Sci Adv. 2023 06 16; 9(24):eadf8332. Luppi AI, Hansen JY, Adapa R, Carhart-Harris RL, Roseman L, Timmermann C, Golkowski D, Ranft A, Ilg R, Jordan D, Bonhomme V, Vanhaudenhuyse A, Demertzi A, Jaquet O, Bahri MA, Alnagger NLN, Cardone P, Peattie ARD, Manktelow AE, de Araujo DB, Sensi SL, Owen AM, Naci L, Menon DK, Misic B, Stamatakis EA. PMID: 37315149; PMCID: PMC10266734.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    46. Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression. Psychol Med. 2024 Jan; 54(1):178-192. Weiss B, Ginige I, Shannon L, Giribaldi B, Murphy-Beiner A, Murphy R, Baker-Jones M, Martell J, Nutt DJ, Carhart-Harris RL, Erritzoe D. PMID: 37264814; PMCID: PMC10692311.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    47. Emerging Challenges for Psychedelic Therapy. JAMA Psychiatry. 2023 06 01; 80(6):533-534. Aday JS, Carhart-Harris RL, Woolley JD. PMID: 37074690.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    48. Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience. bioRxiv. 2023 May 12. Singleton SP, Timmermann C, Luppi AI, Eckernäs E, Roseman L, Carhart-Harris RL, Kuceyeski A. PMID: 37214949; PMCID: PMC10197635.
      View in: PubMed   Mentions:
    49. How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change. J Affect Disord. 2023 08 01; 334:100-112. Zeifman RJ, Wagner AC, Monson CM, Carhart-Harris RL. PMID: 37146908.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    50. A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression. J Psychopharmacol. 2023 07; 37(7):717-732. Weiss B, Erritzoe D, Giribaldi B, Nutt DJ, Carhart-Harris RL. PMID: 37122239; PMCID: PMC10350722.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Increased low-frequency brain responses to music after psilocybin therapy for depression. J Affect Disord. 2023 07 15; 333:321-330. Wall MB, Lam C, Ertl N, Kaelen M, Roseman L, Nutt DJ, Carhart-Harris RL. PMID: 37094657.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    52. A whole-brain model of the neural entropy increase elicited by psychedelic drugs. Sci Rep. 2023 04 17; 13(1):6244. Herzog R, Mediano PAM, Rosas FE, Lodder P, Carhart-Harris R, Perl YS, Tagliazucchi E, Cofre R. PMID: 37069186; PMCID: PMC10110594.
      View in: PubMed   Mentions: 9     Fields:    
    53. Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 07; 8(7):768-776. Delli Pizzi S, Chiacchiaretta P, Sestieri C, Ferretti A, Onofrj M, Della Penna S, Roseman L, Timmermann C, Nutt DJ, Carhart-Harris RL, Sensi SL. PMID: 37003409.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    54. Editorial: Frontiers in psychodynamic neuroscience. Front Hum Neurosci. 2023; 17:1170480. Cieri F, Carhart-Harris RL, Mathys C, Turnbull O, Solms M. PMID: 37033906; PMCID: PMC10073675.
      View in: PubMed   Mentions: 1  
    55. Human brain effects of DMT assessed via EEG-fMRI. Proc Natl Acad Sci U S A. 2023 03 28; 120(13):e2218949120. Timmermann C, Roseman L, Haridas S, Rosas FE, Luan L, Kettner H, Martell J, Erritzoe D, Tagliazucchi E, Pallavicini C, Girn M, Alamia A, Leech R, Nutt DJ, Carhart-Harris RL. PMID: 36940333; PMCID: PMC10068756.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    56. N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysis. CPT Pharmacometrics Syst Pharmacol. 2023 04; 12(4):474-486. Eckernäs E, Timmermann C, Carhart-Harris R, Röshammar D, Ashton M. PMID: 36762714; PMCID: PMC10088084.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. A complex systems perspective on psychedelic brain action. Trends Cogn Sci. 2023 05; 27(5):433-445. Girn M, Rosas FE, Daws RE, Gallen CL, Gazzaley A, Carhart-Harris RL. PMID: 36740518.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    58. LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics. PLoS Comput Biol. 2023 02; 19(2):e1010811. Ruffini G, Damiani G, Lozano-Soldevilla D, Deco N, Rosas FE, Kiani NA, Ponce-Alvarez A, Kringelbach ML, Carhart-Harris R, Deco G. PMID: 36735751; PMCID: PMC9943020.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    59. Translational Challenges in Psychedelic Medicine. N Engl J Med. 2023 02 02; 388(5):476-477. Carhart-Harris RL. PMID: 36724336.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    60. Distributed harmonic patterns of structure-function dependence orchestrate human consciousness. Commun Biol. 2023 01 28; 6(1):117. Luppi AI, Vohryzek J, Kringelbach ML, Mediano PAM, Craig MM, Adapa R, Carhart-Harris RL, Roseman L, Pappas I, Peattie ARD, Manktelow AE, Sahakian BJ, Finoia P, Williams GB, Allanson J, Pickard JD, Menon DK, Atasoy S, Stamatakis EA. PMID: 36709401; PMCID: PMC9884288.
      View in: PubMed   Mentions: 13  Translation:Humans
    61. Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. J Psychopharmacol. 2023 01; 37(1):93-106. Forstmann M, Kettner HS, Sagioglou C, Irvine A, Gandy S, Carhart-Harris RL, Luke D. PMID: 36601974; PMCID: PMC9834326.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Canalization and plasticity in psychopathology. Neuropharmacology. 2023 03 15; 226:109398. Carhart-Harris RL, Chandaria S, Erritzoe DE, Gazzaley A, Girn M, Kettner H, Mediano PAM, Nutt DJ, Rosas FE, Roseman L, Timmermann C, Weiss B, Zeifman RJ, Friston KJ. PMID: 36584883.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    63. Oxygen and the Spark of Human Brain Evolution: Complex Interactions of Metabolism and Cortical Expansion across Development and Evolution. Neuroscientist. 2024 Apr; 30(2):173-198. Luppi AI, Rosas FE, Noonan MP, Mediano PAM, Kringelbach ML, Carhart-Harris RL, Stamatakis EA, Vernon AC, Turkheimer FE. PMID: 36476177; PMCID: PMC10928962.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. J Psychopharmacol. 2023 01; 37(1):70-79. Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. PMID: 36433778; PMCID: PMC9834320.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    65. Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans. Psychol Med. 2022 Nov 22; 1-12. Kanen JW, Luo Q, Rostami Kandroodi M, Cardinal RN, Robbins TW, Nutt DJ, Carhart-Harris RL, den Ouden HEM. PMID: 36411719; PMCID: PMC10600934.
      View in: PubMed   Mentions: 15     Fields:    
    66. Body mass index (BMI) does not predict responses to psilocybin. J Psychopharmacol. 2023 01; 37(1):107-116. Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL. PMID: 36373934; PMCID: PMC9834321.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med. 2022 11 03; 387(18):1637-1648. Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Pálenícek T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E. PMID: 36322843.
      View in: PubMed   Mentions: 159     Fields:    Translation:HumansCTClinical Trials
    68. A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression. Psychedelic Med (New Rochelle). 2023 Mar; 1(1):18-26. Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM, Giribaldi B, Erritzoe D, Nutt DJ, Carhart-Harris R. PMID: 37337526; PMCID: PMC10278160.
      View in: PubMed   Mentions: 1  
    69. Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape. Nat Commun. 2022 10 03; 13(1):5812. Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A. PMID: 36192411; PMCID: PMC9530221.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    70. Effects of classic psychedelic drugs on turbulent signatures in brain dynamics. Netw Neurosci. 2022; 6(4):1104-1124. Cruzat J, Perl YS, Escrichs A, Vohryzek J, Timmermann C, Roseman L, Luppi AI, Ibañez A, Nutt D, Carhart-Harris R, Tagliazucchi E, Deco G, Kringelbach ML. PMID: 38800462; PMCID: PMC11117113.
      View in: PubMed   Mentions: 5  
    71. Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations. Clin Transl Sci. 2022 12; 15(12):2928-2937. Eckernäs E, Timmermann C, Carhart-Harris R, Röshammar D, Ashton M. PMID: 36088656; PMCID: PMC9747126.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    72. Retraction Note: A mechanistic model of the neural entropy increase elicited by psychedelic drugs. Sci Rep. 2022 Sep 15; 12(1):15500. Herzog R, Mediano PAM, Rosas FE, Carhart-Harris R, Perl YS, Tagliazucchi E, Cofre R. PMID: 36109628; PMCID: PMC9477842.
      View in: PubMed   Mentions: 2     Fields:    
    73. Psychedelics and schizophrenia: Distinct alterations to Bayesian inference. Neuroimage. 2022 11; 263:119624. Rajpal H, Mediano PAM, Rosas FE, Timmermann CB, Brugger S, Muthukumaraswamy S, Seth AK, Bor D, Carhart-Harris RL, Jensen HJ. PMID: 36108798; PMCID: PMC7614773.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    74. Effects of psilocybin versus escitalopram on rumination and thought suppression in depression. BJPsych Open. 2022 Sep 06; 8(5):e163. Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R. PMID: 36065128; PMCID: PMC9534928.
      View in: PubMed   Mentions: 10  
    75. The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Psychopharmacology (Berl). 2022 Nov; 239(11):3461-3483. Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L. PMID: 35939083; PMCID: PMC9358368.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    76. Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample. J Psychopharmacol. 2022 08; 36(8):932-942. Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D. PMID: 35924888; PMCID: PMC9353970.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    77. Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Sci Rep. 2022 05 24; 12(1):8562. Lawrence DW, Carhart-Harris R, Griffiths R, Timmermann C. PMID: 35610230; PMCID: PMC9130218.
      View in: PubMed   Mentions: 11     Fields:    
    78. Greater than the parts: a review of the information decomposition approach to causal emergence. Philos Trans A Math Phys Eng Sci. 2022 Jul 11; 380(2227):20210246. Mediano PAM, Rosas FE, Luppi AI, Jensen HJ, Seth AK, Barrett AB, Carhart-Harris RL, Bor D. PMID: 35599558; PMCID: PMC9125226.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    79. Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses. Neurosci Biobehav Rev. 2022 07; 138:104689. McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM. PMID: 35588933.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    80. Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. Neuroimage. 2022 08 01; 256:119220. Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R. PMID: 35483649.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    81. Increased global integration in the brain after psilocybin therapy for depression. Nat Med. 2022 04; 28(4):844-851. Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R. PMID: 35411074.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCTClinical Trials
    82. Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Front Pharmacol. 2021; 12:788155. Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R. PMID: 35431912; PMCID: PMC9009076.
      View in: PubMed   Mentions: 33  
    83. Consciousness is supported by near-critical slow cortical electrodynamics. Proc Natl Acad Sci U S A. 2022 02 15; 119(7). Toker D, Pappas I, Lendner JD, Frohlich J, Mateos DM, Muthukumaraswamy S, Carhart-Harris R, Paff M, Vespa PM, Monti MM, Sommer FT, Knight RT, D'Esposito M. PMID: 35145021; PMCID: PMC8851554.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimals
    84. Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma. J Pharm Biomed Anal. 2022 Apr 01; 212:114642. Eckernäs E, Bendrioua A, Cancellerini C, Timmermann C, Carhart-Harris R, Hoffmann KJ, Ashton M. PMID: 35149418.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    85. Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience. J Psychopharmacol. 2022 01; 36(1):31-45. Peill JM, Trinci KE, Kettner H, Mertens LJ, Roseman L, Timmermann C, Rosas FE, Lyons T, Carhart-Harris RL. PMID: 34983255; PMCID: PMC8801624.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    86. Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of Personality. Front Psychol. 2021; 12:749788. Weiss B, Nygart V, Pommerencke LM, Carhart-Harris RL, Erritzoe D. PMID: 34899488; PMCID: PMC8655335.
      View in: PubMed   Mentions: 10  
    87. Psychedelics alter metaphysical beliefs. Sci Rep. 2021 11 23; 11(1):22166. Timmermann C, Kettner H, Letheby C, Roseman L, Rosas FE, Carhart-Harris RL. PMID: 34815421; PMCID: PMC8611059.
      View in: PubMed   Mentions: 40     Fields:    
    88. What it is like to be a bit: an integrated information decomposition account of emergent mental phenomena. Neurosci Conscious. 2021; 2021(2):niab027. Luppi AI, Mediano PAM, Rosas FE, Harrison DJ, Carhart-Harris RL, Bor D, Stamatakis EA. PMID: 34804593; PMCID: PMC8600547.
      View in: PubMed   Mentions: 9  
    89. Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research. Front Psychiatry. 2021; 12:735427. Bornemann J, Close JB, Spriggs MJ, Carhart-Harris R, Roseman L. PMID: 34867525; PMCID: PMC8632941.
      View in: PubMed   Mentions: 8  
    90. Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey. Psychopharmacology (Berl). 2022 May; 239(5):1425-1440. Kuc J, Kettner H, Rosas F, Erritzoe D, Haijen E, Kaelen M, Nutt D, Carhart-Harris RL. PMID: 34734314; PMCID: PMC9110465.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    91. Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study". Front Psychiatry. 2021; 12:735523. Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL. PMID: 34744825; PMCID: PMC8563607.
      View in: PubMed   Mentions: 22  
    92. Co-design of Guidance for Patient and Public Involvement in Psychedelic Research. Front Psychiatry. 2021; 12:727496. Close JB, Bornemann J, Piggin M, Jayacodi S, Luan LX, Carhart-Harris R, Spriggs MJ. PMID: 34658961; PMCID: PMC8514741.
      View in: PubMed   Mentions: 8  
    93. Prefrontal contributions to the stability and variability of thought and conscious experience. Neuropsychopharmacology. 2022 01; 47(1):329-348. Zamani A, Carhart-Harris R, Christoff K. PMID: 34545195; PMCID: PMC8616944.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    94. Psilocybin for Depression. Reply. N Engl J Med. 2021 08 26; 385(9):863-864. Carhart-Harris R, Blemings A, Nutt DJ. PMID: 34437798.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    95. Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use. J Med Internet Res. 2021 07 28; 23(7):e25973. Hübner S, Haijen E, Kaelen M, Carhart-Harris RL, Kettner H. PMID: 34319246; PMCID: PMC8367105.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    96. Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential? Front Psychiatry. 2021; 12:661233. Kocárová R, Horácek J, Carhart-Harris R. PMID: 34349678; PMCID: PMC8327748.
      View in: PubMed   Mentions: 20  
    97. Losing the Self in Near-Death Experiences: The Experience of Ego-Dissolution. Brain Sci. 2021 Jul 14; 11(7). Martial C, Fontaine G, Gosseries O, Carhart-Harris R, Timmermann C, Laureys S, Cassol H. PMID: 34356163; PMCID: PMC8307473.
      View in: PubMed   Mentions: 7  
    98. Associations between lifetime classic psychedelic use and cardiometabolic diseases. Sci Rep. 2021 Jul 13; 11(1):14427. Simonsson O, Osika W, Carhart-Harris R, Hendricks PS. PMID: 34257396; PMCID: PMC8277805.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    99. Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample. Front Psychiatry. 2021; 12:647909. Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL. PMID: 34267683; PMCID: PMC8277190.
      View in: PubMed   Mentions: 12  
    100. Psychedelics and health behaviour change. J Psychopharmacol. 2022 01; 36(1):12-19. Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL. PMID: 34053342; PMCID: PMC8801670.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    101. Relational Processes in Ayahuasca Groups of Palestinians and Israelis. Front Pharmacol. 2021; 12:607529. Roseman L, Ron Y, Saca A, Ginsberg N, Luan L, Karkabi N, Doblin R, Carhart-Harris R. PMID: 34093170; PMCID: PMC8170481.
      View in: PubMed   Mentions: 14  
    102. Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine? J Psychopharmacol. 2022 01; 36(1):6-11. Carhart-Harris RL, Wagner AC, Agrawal M, Kettner H, Rosenbaum JF, Gazzaley A, Nutt DJ, Erritzoe D. PMID: 33888025; PMCID: PMC8801625.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    103. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021 04 15; 384(15):1402-1411. Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ. PMID: 33852780.
      View in: PubMed   Mentions: 311     Fields:    Translation:HumansCTClinical Trials
    104. Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness. Front Pharmacol. 2021; 12:623985. Kettner H, Rosas FE, Timmermann C, Kärtner L, Carhart-Harris RL, Roseman L. PMID: 33995022; PMCID: PMC8114773.
      View in: PubMed   Mentions: 47  
    105. Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year. Hypertension. 2021 05 05; 77(5):1510-1516. Simonsson O, Hendricks PS, Carhart-Harris R, Kettner H, Osika W. PMID: 33677982.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    106. Self-blinding citizen science to explore psychedelic microdosing. Elife. 2021 03 02; 10. Szigeti B, Kartner L, Blemings A, Rosas F, Feilding A, Nutt DJ, Carhart-Harris RL, Erritzoe D. PMID: 33648632; PMCID: PMC7925122.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    107. Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings. J Psychopharmacol. 2021 04; 35(4):406-420. Pallavicini C, Cavanna F, Zamberlan F, de la Fuente LA, Ilksoy Y, Perl YS, Arias M, Romero C, Carhart-Harris R, Timmermann C, Tagliazucchi E. PMID: 33567945.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    108. Trends in the Top-Cited Articles on Classic Psychedelics. J Psychoactive Drugs. 2021 Sep-Oct; 53(4):283-298. Lawrence DW, Sharma B, Griffiths RR, Carhart-Harris R. PMID: 33535907.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    109. The Current Status of Psychedelics in Psychiatry. JAMA Psychiatry. 2021 02 01; 78(2):121-122. Nutt D, Carhart-Harris R. PMID: 32725172.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    110. Increased sensitivity to strong perturbations in a whole-brain model of LSD. Neuroimage. 2021 04 15; 230:117809. Jobst BM, Atasoy S, Ponce-Alvarez A, Sanjuán A, Roseman L, Kaelen M, Carhart-Harris R, Kringelbach ML, Deco G. PMID: 33524579; PMCID: PMC8063176.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    111. Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing. Sci Rep. 2021 01 21; 11(1):1941. Kaertner LS, Steinborn MB, Kettner H, Spriggs MJ, Roseman L, Buchborn T, Balaet M, Timmermann C, Erritzoe D, Carhart-Harris RL. PMID: 33479342; PMCID: PMC7820236.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    112. Reconciling emergences: An information-theoretic approach to identify causal emergence in multivariate data. PLoS Comput Biol. 2020 12; 16(12):e1008289. Rosas FE, Mediano PAM, Jensen HJ, Seth AK, Barrett AB, Carhart-Harris RL, Bor D. PMID: 33347467; PMCID: PMC7833221.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    113. LSD alters dynamic integration and segregation in the human brain. Neuroimage. 2021 02 15; 227:117653. Luppi AI, Carhart-Harris RL, Roseman L, Pappas I, Menon DK, Stamatakis EA. PMID: 33338615; PMCID: PMC7896102.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    114. The entropic tongue: Disorganization of natural language under LSD. Conscious Cogn. 2021 01; 87:103070. Sanz C, Pallavicini C, Carrillo F, Zamberlan F, Sigman M, Mota N, Copelli M, Ribeiro S, Nutt D, Carhart-Harris R, Tagliazucchi E. PMID: 33307427.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    115. The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health. Health Psychol Open. 2020 Jul-Dec; 7(2):2055102920978123. Gandy S, Forstmann M, Carhart-Harris RL, Timmermann C, Luke D, Watts R. PMID: 33335742; PMCID: PMC7724423.
      View in: PubMed   Mentions: 15  
    116. Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison. Schizophr Bull. 2020 12 01; 46(6):1396-1408. Leptourgos P, Fortier-Davy M, Carhart-Harris R, Corlett PR, Dupuis D, Halberstadt AL, Kometer M, Kozakova E, LarØi F, Noorani TN, Preller KH, Waters F, Zaytseva Y, Jardri R. PMID: 32944778; PMCID: PMC7707069.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    117. Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatr Scand. 2021 02; 143(2):101-118. Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. PMID: 33125716.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    118. Pivotal mental states. J Psychopharmacol. 2021 04; 35(4):319-352. Brouwer A, Carhart-Harris RL. PMID: 33174492; PMCID: PMC8054165.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    119. Correction: DMT alters cortical travelling waves. Elife. 2020 Nov 09; 9. Alamia A, Timmermann C, Nutt DJ, VanRullen R, Carhart-Harris RL. PMID: 33164747; PMCID: PMC7652412.
      View in: PubMed   Mentions: 1     Fields:    
    120. A mechanistic model of the neural entropy increase elicited by psychedelic drugs. Sci Rep. 2020 10 20; 10(1):17725. Herzog R, Mediano PAM, Rosas FE, Carhart-Harris R, Perl YS, Tagliazucchi E, Cofre R. PMID: 33082424; PMCID: PMC7575594.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    121. DMT alters cortical travelling waves. Elife. 2020 10 12; 9. Alamia A, Timmermann C, Nutt DJ, VanRullen R, Carhart-Harris RL. PMID: 33043883; PMCID: PMC7577737.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    122. Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder. Eat Weight Disord. 2021 May; 26(4):1265-1270. Spriggs MJ, Kettner H, Carhart-Harris RL. PMID: 32895801.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    123. Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation. Front Psychiatry. 2020; 11:782. Zeifman RJ, Wagner AC, Watts R, Kettner H, Mertens LJ, Carhart-Harris RL. PMID: 32903724; PMCID: PMC7438781.
      View in: PubMed   Mentions: 33  
    124. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains. Neuroimage. 2020 10 15; 220:117049. Varley TF, Carhart-Harris R, Roseman L, Menon DK, Stamatakis EA. PMID: 32619708.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    125. Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. J Psychopharmacol. 2021 05; 35(5):547-555. Borissova A, Ferguson B, Wall MB, Morgan CJ, Carhart-Harris RL, Bolstridge M, Bloomfield MA, Williams TM, Feilding A, Murphy K, Tyacke RJ, Erritzoe D, Stewart L, Wolff K, Nutt D, Curran HV, Lawn W. PMID: 32538252; PMCID: PMC8155732.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    126. Dynamic coupling of whole-brain neuronal and neurotransmitter systems. Proc Natl Acad Sci U S A. 2020 04 28; 117(17):9566-9576. Kringelbach ML, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris R, Whybrow PC, Logothetis NK, Deco G. PMID: 32284420; PMCID: PMC7196827.
      View in: PubMed   Mentions: 75     Fields:    Translation:Cells
    127. Psychedelic Psychiatry's Brave New World. Cell. 2020 04 02; 181(1):24-28. Nutt D, Erritzoe D, Carhart-Harris R. PMID: 32243793.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    128. Updating the dynamic framework of thought: Creativity and psychedelics. Neuroimage. 2020 06; 213:116726. Girn M, Mills C, Roseman L, Carhart-Harris RL, Christoff K. PMID: 32160951.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    129. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. J Psychopharmacol. 2020 02; 34(2):167-180. Mertens LJ, Wall MB, Roseman L, Demetriou L, Nutt DJ, Carhart-Harris RL. PMID: 31941394.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    130. Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers. Psychopharmacology (Berl). 2020 Mar; 237(3):841-853. Family N, Maillet EL, Williams LTJ, Krediet E, Carhart-Harris RL, Williams TM, Nichols CD, Goble DJ, Raz S. PMID: 31853557; PMCID: PMC7036065.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    131. Decreased directed functional connectivity in the psychedelic state. Neuroimage. 2020 04 01; 209:116462. Barnett L, Muthukumaraswamy SD, Carhart-Harris RL, Seth AK. PMID: 31857204.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    132. From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner. Int J Environ Res Public Health. 2019 12 16; 16(24). Kettner H, Gandy S, Haijen ECHM, Carhart-Harris RL. PMID: 31888300; PMCID: PMC6949937.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    133. Neural correlates of the DMT experience assessed with multivariate EEG. Sci Rep. 2019 11 19; 9(1):16324. Timmermann C, Roseman L, Schartner M, Milliere R, Williams LTJ, Erritzoe D, Muthukumaraswamy S, Ashton M, Bendrioua A, Kaur O, Turton S, Nour MM, Day CM, Leech R, Nutt DJ, Carhart-Harris RL. PMID: 31745107; PMCID: PMC6864083.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    134. Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. J Psychopharmacol. 2019 09; 33(9):1076-1087. Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R. PMID: 31294673.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    135. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. Pharmacol Rev. 2019 07; 71(3):316-344. Carhart-Harris RL, Friston KJ. PMID: 31221820; PMCID: PMC6588209.
      View in: PubMed   Mentions: 236     Fields:    Translation:HumansAnimals
    136. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives. Neuroimage. 2019 10 15; 200:281-291. Pallavicini C, Vilas MG, Villarreal M, Zamberlan F, Muthukumaraswamy S, Nutt D, Carhart-Harris R, Tagliazucchi E. PMID: 31247301.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    137. Replication and extension of a model predicting response to psilocybin. Psychopharmacology (Berl). 2019 Nov; 236(11):3221-3230. Russ SL, Carhart-Harris RL, Maruyama G, Elliott MS. PMID: 31203401.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    138. Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin. Neuroimage. 2019 10 01; 199:127-142. Lord LD, Expert P, Atasoy S, Roseman L, Rapuano K, Lambiotte R, Nutt DJ, Deco G, Carhart-Harris RL, Kringelbach ML, Cabral J. PMID: 31132450.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    139. Psychedelics as a treatment for disorders of consciousness. Neurosci Conscious. 2019; 2019(1):niz003. Scott G, Carhart-Harris RL. PMID: 31024740; PMCID: PMC6475593.
      View in: PubMed   Mentions: 25  
    140. Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers. J Psychopharmacol. 2019 09; 33(9):1068-1075. Erritzoe D, Smith J, Fisher PM, Carhart-Harris R, Frokjaer VG, Knudsen GM. PMID: 30816797.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    141. How do psychedelics work? Curr Opin Psychiatry. 2019 01; 32(1):16-21. Carhart-Harris RL. PMID: 30394903.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    142. Predicting Responses to Psychedelics: A Prospective Study. Front Pharmacol. 2018; 9:897. Haijen ECHM, Kaelen M, Roseman L, Timmermann C, Kettner H, Russ S, Nutt D, Daws RE, Hampshire ADG, Lorenz R, Carhart-Harris RL. PMID: 30450045; PMCID: PMC6225734.
      View in: PubMed   Mentions: 113  
    143. Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition. Prog Brain Res. 2018; 242:97-120. Atasoy S, Vohryzek J, Deco G, Carhart-Harris RL, Kringelbach ML. PMID: 30471684.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    144. More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression. Front Psychol. 2018; 9:1721. Lyons T, Carhart-Harris RL. PMID: 30369890; PMCID: PMC6194345.
      View in: PubMed   Mentions: 19  
    145. Serotonin, psychedelics and psychiatry. World Psychiatry. 2018 Oct; 17(3):358-359. Carhart-Harris RL. PMID: 30192100; PMCID: PMC6127802.
      View in: PubMed   Mentions: 12  
    146. Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD. Curr Biol. 2018 10 08; 28(19):3065-3074.e6. Deco G, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris RL, Whybrow PC, Logothetis NK, Kringelbach ML. PMID: 30270185.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    147. Psychedelics, Meditation, and Self-Consciousness. Front Psychol. 2018; 9:1475. Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A. PMID: 30245648; PMCID: PMC6137697.
      View in: PubMed   Mentions: 87  
    148. DMT Models the Near-Death Experience. Front Psychol. 2018; 9:1424. Timmermann C, Roseman L, Williams L, Erritzoe D, Martial C, Cassol H, Laureys S, Nutt D, Carhart-Harris R. PMID: 30174629; PMCID: PMC6107838.
      View in: PubMed   Mentions: 56  
    149. Effects of psilocybin therapy on personality structure. Acta Psychiatr Scand. 2018 11; 138(5):368-378. Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL. PMID: 29923178; PMCID: PMC6220878.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    150. Psilocybin and MDMA reduce costly punishment in the Ultimatum Game. Sci Rep. 2018 05 29; 8(1):8236. Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA. PMID: 29844496; PMCID: PMC5974271.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    151. Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology (Berl). 2018 05; 235(5):1623. Kaelen M, Giribaldi B, Raine J, Evans L, Timmermann C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R. PMID: 29582103; PMCID: PMC6713697.
      View in: PubMed   Mentions: 4     Fields:    
    152. Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression. J Affect Disord. 2018 04 01; 230:84-86. Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL. PMID: 29407543.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    153. The entropic brain - revisited. Neuropharmacology. 2018 11; 142:167-178. Carhart-Harris RL. PMID: 29548884.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansAnimals
    154. Psychedelics and the essential importance of context. J Psychopharmacol. 2018 07; 32(7):725-731. Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M. PMID: 29446697.
      View in: PubMed   Mentions: 168     Fields:    Translation:HumansAnimals
    155. The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology (Berl). 2018 02; 235(2):505-519. Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R. PMID: 29396616; PMCID: PMC5893695.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    156. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. Front Pharmacol. 2017; 8:974. Roseman L, Nutt DJ, Carhart-Harris RL. PMID: 29387009; PMCID: PMC5776504.
      View in: PubMed   Mentions: 207  
    157. Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. J Psychopharmacol. 2018 07; 32(7):811-819. Lyons T, Carhart-Harris RL. PMID: 29338538; PMCID: PMC6047302.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    158. Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. Neuropharmacology. 2018 11; 142:263-269. Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL. PMID: 29288686.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCTClinical Trials
    159. Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD. Sci Rep. 2017 12 15; 7(1):17661. Atasoy S, Roseman L, Kaelen M, Kringelbach ML, Deco G, Carhart-Harris RL. PMID: 29247209; PMCID: PMC5732294.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    160. LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm. Neuropharmacology. 2018 11; 142:251-262. Timmermann C, Spriggs MJ, Kaelen M, Leech R, Nutt DJ, Moran RJ, Carhart-Harris RL, Muthukumaraswamy SD. PMID: 29101022.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    161. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology (Berl). 2018 02; 235(2):399-408. Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ. PMID: 29119217; PMCID: PMC5813086.
      View in: PubMed   Mentions: 247     Fields:    Translation:HumansCTClinical Trials
    162. Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology (Berl). 2018 02; 235(2):459-466. Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL. PMID: 29085980; PMCID: PMC5813058.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    163. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Sci Rep. 2017 10 13; 7(1):13187. Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ. PMID: 29030624; PMCID: PMC5640601.
      View in: PubMed   Mentions: 147     Fields:    Translation:HumansCTClinical Trials
    164. Serotonin and brain function: a tale of two receptors. J Psychopharmacol. 2017 09; 31(9):1091-1120. Carhart-Harris RL, Nutt DJ. PMID: 28858536; PMCID: PMC5606297.
      View in: PubMed   Mentions: 219     Fields:    Translation:HumansAnimalsCells
    165. Psychedelics and connectedness. Psychopharmacology (Berl). 2018 02; 235(2):547-550. Carhart-Harris RL, Erritzoe D, Haijen E, Kaelen M, Watts R. PMID: 28795211.
      View in: PubMed   Mentions: 68     Fields:    
    166. Psychedelics, Personality and Political Perspectives. J Psychoactive Drugs. 2017 Jul-Aug; 49(3):182-191. Nour MM, Evans L, Carhart-Harris RL. PMID: 28443703.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    167. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology. 2017 Oct; 42(11):2105-2113. Carhart-Harris RL, Goodwin GM. PMID: 28443617; PMCID: PMC5603818.
      View in: PubMed   Mentions: 159     Fields:    Translation:HumansAnimals
    168. Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Sci Rep. 2017 04 19; 7:46421. Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD. PMID: 28422113; PMCID: PMC5396066.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    169. Psychedelics and the science of self-experience. Br J Psychiatry. 2017 03; 210(3):177-179. Nour MM, Carhart-Harris RL. PMID: 28249943.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    170. Concerns regarding conclusions made about LSD-treatments (received 25 October 2016). Hist Psychiatry. 2017 Jun; 28(2):257-260. Erritzoe D, Nutt DJ, Carhart-Harris R. PMID: 28198192.
      View in: PubMed   Mentions: 2     Fields:    
    171. Altered Insula Connectivity under MDMA. Neuropsychopharmacology. 2017 Oct; 42(11):2152-2162. Walpola IC, Nest T, Roseman L, Erritzoe D, Feilding A, Nutt DJ, Carhart-Harris RL. PMID: 28195139; PMCID: PMC5603811.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    172. Question-based Drug Development for psilocybin - Authors' reply. Lancet Psychiatry. 2016 Sep; 3(9):807. Carhart-Harris RL, Nutt DJ. PMID: 27568266.
      View in: PubMed   Mentions: 1     Fields:    
    173. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI). Front Hum Neurosci. 2016; 10:269. Nour MM, Evans L, Nutt D, Carhart-Harris RL. PMID: 27378878; PMCID: PMC4906025.
      View in: PubMed   Mentions: 130  
    174. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry. 2016 Jul; 3(7):619-27. Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ. PMID: 27210031.
      View in: PubMed   Mentions: 418     Fields:    Translation:HumansCTClinical Trials
    175. LSD-induced entropic brain activity predicts subsequent personality change. Hum Brain Mapp. 2016 09; 37(9):3203-13. Lebedev AV, Kaelen M, Lövdén M, Nilsson J, Feilding A, Nutt DJ, Carhart-Harris RL. PMID: 27151536; PMCID: PMC6867426.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCTClinical Trials
    176. LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion. Hum Brain Mapp. 2016 08; 37(8):3031-40. Roseman L, Sereno MI, Leech R, Kaelen M, Orban C, McGonigle J, Feilding A, Nutt DJ, Carhart-Harris RL. PMID: 27125770; PMCID: PMC6867480.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    177. Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution. Curr Biol. 2016 04 25; 26(8):1043-50. Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, Laufs H, Leech R, McGonigle J, Crossley N, Bullmore E, Williams T, Bolstridge M, Feilding A, Nutt DJ, Carhart-Harris R. PMID: 27085214.
      View in: PubMed   Mentions: 150     Fields:    Translation:Humans
    178. LSD modulates music-induced imagery via changes in parahippocampal connectivity. Eur Neuropsychopharmacol. 2016 07; 26(7):1099-109. Kaelen M, Roseman L, Kahan J, Santos-Ribeiro A, Orban C, Lorenz R, Barrett FS, Bolstridge M, Williams T, Williams L, Wall MB, Feilding A, Muthukumaraswamy S, Nutt DJ, Carhart-Harris R. PMID: 27084302.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    179. Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A. 2016 Apr 26; 113(17):4853-8. Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, McGonigle J, Sereno MI, Nichols D, Hellyer PJ, Hobden P, Evans J, Singh KD, Wise RG, Curran HV, Feilding A, Nutt DJ. PMID: 27071089; PMCID: PMC4855588.
      View in: PubMed   Mentions: 260     Fields:    Translation:HumansCells
    180. A placebo-controlled investigation of synaesthesia-like experiences under LSD. Neuropsychologia. 2016 07 29; 88:28-34. Terhune DB, Luke DP, Kaelen M, Bolstridge M, Feilding A, Nutt D, Carhart-Harris R, Ward J. PMID: 27059209.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    181. Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide. J Psychopharmacol. 2016 Apr; 30(4):344-53. Speth J, Speth C, Kaelen M, Schloerscheidt AM, Feilding A, Nutt DJ, Carhart-Harris RL. PMID: 26979587.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    182. The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychol Med. 2016 May; 46(7):1379-90. Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, Feilding A, Nutt DJ. PMID: 26847689.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    183. LSD enhances the emotional response to music. Psychopharmacology (Berl). 2015 Oct; 232(19):3607-14. Kaelen M, Barrett FS, Roseman L, Lorenz R, Family N, Bolstridge M, Curran HV, Feilding A, Nutt DJ, Carhart-Harris RL. PMID: 26257162.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    184. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin. Hum Brain Mapp. 2015 Aug; 36(8):3137-53. Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL. PMID: 26010878; PMCID: PMC6869189.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    185. Drug models of schizophrenia. Ther Adv Psychopharmacol. 2015 Feb; 5(1):43-58. Steeds H, Carhart-Harris RL, Stone JM. PMID: 25653831; PMCID: PMC4315669.
      View in: PubMed   Mentions: 52  
    186. Homological scaffolds of brain functional networks. J R Soc Interface. 2014 Dec 06; 11(101):20140873. Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer PJ, Vaccarino F. PMID: 25401177; PMCID: PMC4223908.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    187. LSD enhances suggestibility in healthy volunteers. Psychopharmacology (Berl). 2015 Feb; 232(4):785-94. Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ. PMID: 25242255.
      View in: PubMed   Mentions: 88     Fields:    Translation:Humans
    188. Enhanced repertoire of brain dynamical states during the psychedelic experience. Hum Brain Mapp. 2014 Nov; 35(11):5442-56. Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR. PMID: 24989126; PMCID: PMC6869695.
      View in: PubMed   Mentions: 124     Fields:    Translation:Humans
    189. Spatial dependencies between large-scale brain networks. PLoS One. 2014; 9(6):e98500. Leech R, Scott G, Carhart-Harris R, Turkheimer F, Taylor-Robinson SD, Sharp DJ. PMID: 24887067; PMCID: PMC4041825.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    190. The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers. Front Hum Neurosci. 2014; 8:204. Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL. PMID: 24904346; PMCID: PMC4034428.
      View in: PubMed   Mentions: 65  
    191. Was it a vision or a waking dream? Front Psychol. 2014; 5:255. Carhart-Harris R, Nutt D. PMID: 24772095; PMCID: PMC3983501.
      View in: PubMed   Mentions: 11  
    192. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. Front Hum Neurosci. 2014; 8:20. Carhart-Harris RL, Leech R, Hellyer PJ, Shanahan M, Feilding A, Tagliazucchi E, Chialvo DR, Nutt D. PMID: 24550805; PMCID: PMC3909994.
      View in: PubMed   Mentions: 324  
    193. The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity. Biol Psychiatry. 2015 Oct 15; 78(8):554-62. Carhart-Harris RL, Murphy K, Leech R, Erritzoe D, Wall MB, Ferguson B, Williams LT, Roseman L, Brugger S, De Meer I, Tanner M, Tyacke R, Wolff K, Sethi A, Bloomfield MA, Williams TM, Bolstridge M, Stewart L, Morgan C, Newbould RD, Feilding A, Curran HV, Nutt DJ. PMID: 24495461; PMCID: PMC4578244.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    194. A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment. Curr Drug Abuse Rev. 2014; 7(2):117-27. Turton S, Nutt DJ, Carhart-Harris RL. PMID: 25563444.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    195. The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. Int J Neuropsychopharmacol. 2014 Apr; 17(4):527-40. Carhart-Harris RL, Wall MB, Erritzoe D, Kaelen M, Ferguson B, De Meer I, Tanner M, Bloomfield M, Williams TM, Bolstridge M, Stewart L, Morgan CJ, Newbould RD, Feilding A, Curran HV, Nutt DJ. PMID: 24345398.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    196. Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci. 2013 Sep 18; 33(38):15171-83. Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Errtizoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ. PMID: 24048847; PMCID: PMC6618409.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    197. Experienced drug users assess the relative harms and benefits of drugs: a web-based survey. J Psychoactive Drugs. 2013 Sep-Oct; 45(4):322-8. Carhart-Harris RL, Nutt DJ. PMID: 24377171.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    198. Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. J Psychopharmacol. 2013 Sep; 27(9):771-8. Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. PMID: 23784738.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    199. Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophr Bull. 2013 Nov; 39(6):1343-51. Carhart-Harris RL, Leech R, Erritzoe D, Williams TM, Stone JM, Evans J, Sharp DJ, Feilding A, Wise RG, Nutt DJ. PMID: 23044373; PMCID: PMC3796071.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    200. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. Br J Psychiatry. 2012 Mar; 200(3):238-44. Carhart-Harris RL, Leech R, Williams TM, Erritzoe D, Abbasi N, Bargiotas T, Hobden P, Sharp DJ, Evans J, Feilding A, Wise RG, Nutt DJ. PMID: 22282432.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    201. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A. 2012 Feb 07; 109(6):2138-43. Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ. PMID: 22308440; PMCID: PMC3277566.
      View in: PubMed   Mentions: 316     Fields:    Translation:HumansCTClinical Trials
    202. A web-based survey on mephedrone. Drug Alcohol Depend. 2011 Oct 01; 118(1):19-22. Carhart-Harris RL, King LA, Nutt DJ. PMID: 21420252.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    203. The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability. J Psychopharmacol. 2011 Nov; 25(11):1562-7. Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ. PMID: 20395317.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    204. The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas. Brain. 2010 Apr; 133(Pt 4):1265-83. Carhart-Harris RL, Friston KJ. PMID: 20194141; PMCID: PMC2850580.
      View in: PubMed   Mentions: 140     Fields:    Translation:HumansAnimals
    205. Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls. Psychopharmacology (Berl). 2009 Oct; 206(2):187-96. Carhart-Harris RL, Nutt DJ, Munafo MR, Christmas DM, Wilson SJ. PMID: 19585107.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    206. Mourning and melancholia revisited: correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry. Ann Gen Psychiatry. 2008 Jul 24; 7:9. Carhart-Harris RL, Mayberg HS, Malizia AL, Nutt D. PMID: 18652673; PMCID: PMC2515304.
      View in: PubMed   Mentions: 12  
    207. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J Psychopharmacol. 2009 May; 23(3):249-57. Carhart-Harris RL, Nutt DJ, Munafò M, Wilson SJ. PMID: 18562419.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    Robin's Networks
    Concepts (289)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.